Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29389017 | 1.00 | RAB9A (0.34) | RAB9ALMNAMAPK10MEN1KMT2A | |
| SCHEMBL29386113 | 0.83 | MAPT (0.36) | RAB9ALMNAMEN1KMT2AEHMT2 | |
| SCHEMBL42875 | 0.83 | MAPT (0.36) | RAB9ALMNAMEN1KMT2AEHMT2 | |
| SCHEMBL5153054 | 0.80 | SMN1; SMN2 (0.39) | RAB9ALMNAMEN1KMT2AEHMT2 | |
| SCHEMBL8341133 | 0.77 | KDM4E (0.39) | MEN1KMT2ASMN1; SMN2KDM4ETSHR | |
| SCHEMBL29351145 | 0.77 | LMNA (0.38) | RAB9ALMNAMEN1KMT2AEHMT2 | |
| SCHEMBL321113 | 0.77 | LMNA (0.38) | RAB9ALMNAMEN1KMT2AEHMT2 | |
| SCHEMBL8610607 | 0.77 | LMNA (0.38) | RAB9ALMNAMEN1KMT2AEHMT2 | |
| SCHEMBL1746858 | 0.76 | ALDH1A1 (0.35) | RAB9ALMNAMAPK10MEN1KMT2A | |
| SCHEMBL5502675 | 0.76 | LMNA (0.36) | RAB9ALMNAMAPK10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111902148-B | Compositions and methods for treating muscular atrophy and tonic muscular dystrophy | 艾维迪提生物科学公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118267396-A | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118265544-A | Compositions and methods for treating facial shoulder brachial muscular dystrophy | 艾维迪提生物科学公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-113929738-B | Antibody-drug conjugates | 第一三共株式会社 | 2024-05-17 | — | — | CN | disclosed |
| CN-116063505-B | Anti-GAL 3 antibodies and uses thereof | 真和制药有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117916269-A | Method for preventing aggregation of proteins | 真和制药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117897406-A | anti-GAL 3 antibodies and methods for their use in insulin resistance | 真和制药有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-111655268-B | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-113423735-B | Anti-claudin antibodies and uses thereof | 再鼎医药(上海)有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117561080-A | anti-GAL 3 antibody formulations and methods of use thereof | 真和制药有限公司 | 2024-02-13 | — | — | CN | disclosed |
| EP-1781685-A1 | THERAPEUTIC AND DIAGNOSTIC AGENTS | The Walter and Eliza Hall Institute of Medical Research (AU) | 2007-05-09 | — | — | EP | disclosed |
| US-7048929-B1 | approximates conformational discontinuous epitopes of a primate lentivirus envelope protein, modifications of the structure has enhanced stability, raises a greater range of antibodies to conserved epitopes, and/or has enhanced immunogenicity for broadly neutralizing epitopes. | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2006-05-23 | — | — | US | disclosed |
| US-20060067944-A1 | Stable immunogenic product comprising antigenic heterocomplexes | NEOVACS (FR) | 2006-03-30 | — | — | US | disclosed |
| WO-2006007667-A1 | THERAPEUTIC AND DIAGNOSTIC AGENTS | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2006-01-26 | — | — | WO | disclosed |
| US-20060013800-A1 | Stable immunogenic product comprising antigenic heterocomplexes | NEOVACS (FR) | 2006-01-19 | — | — | US | disclosed |
| US-20050170439-A1 | Methods for Detecting Receptor Complexes Comprising PI3K | ACLARA BIOSCIENCES, INC. | 2005-08-04 | — | — | US | disclosed |
| US-20050170438-A1 | Methods for Detecting Receptor Complexes Comprising PDGFR | MONOGRAM BIOSCIENCES, INC. | 2005-08-04 | — | — | US | disclosed |
| US-20040253636-A1 | Method of protein analysis | OXFORD GLYCOSCIENCES (UK) LTD. (GB) | 2004-12-16 | — | — | US | disclosed |
| EP-1430307-A2 | A METHOD OF PROTEIN ANALYSIS | Oxford GlycoSciences (UK) Ltd, Attn: Mary Gadsden (GB) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003027681-A2 | A METHOD OF PROTEIN ANALYSIS | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-04-03 | — | — | WO | disclosed |